跳至主要内容
临床试验/ACTRN12621000609853
ACTRN12621000609853已完成未知

The effects of an Ocimum tenuiflorum (Holy Basil) extract on perceived stress, mood, sleep, and the stress response in healthy adults experiencing high stress: a randomised, double-blind, placebo-controlled trial

Clinical Research Australia0 个研究点目标入组 100 人开始时间: 2021年5月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Adults aged 18-65 years of age
  • 2. Body mass index between 18.5 kg/m2 and 30 kg/m2
  • 3. Currently experiencing high stress (as determined by a Perceived Stress Scale score of 14 or higher)
  • 4. Stressor or anxiety has been present for greater than a month
  • 5. Self-reported sleep difficulties (as determined by a rating of 3 or higher on at least one of the first 5 questions of the Insomnia Symptom Questionnaire)
  • 6. Medication-free for at least 3 months. Use of analgesics (once a week) or contraceptive pill are permissible.
  • 7. Non-smoker
  • 8. No plan to commence new treatments over the study period
  • 9. Willing to wear a Fitbit to bed for the duration of the study
  • 10. Willing to provide a personally-signed informed consent form detailing all pertinent aspects of the trial.
  • 11. Willing and able to take prescribed capsules for 8 weeks

排除标准

  • 1. Anticipated major stressor, change or medical procedure occurring during the study period likely to affect psychological or physical status
  • 2. Participation in another clinical trial within 30 days before screening
  • 3. Suffer from mental-health disorder other than mild depressive or anxiety symptoms as measured by Patient Health Questionnaire-4
  • 4. Suffering from recently diagnosed or unmanaged medical conditions including but not limited to: diabetes, hyper/hypotension, cardiovascular disease, a gastrointestinal disease requiring regular use of medications, gallbladder disease/ gallstones/ biliary disease, autoimmune disease, endocrine disease, and acute or chronic pain condition
  • 5. Alcohol consumption greater than 14 standard drinks per week
  • 6. Current or 12-month history of illicit drug abuse
  • 7. Caffeine intake greater than 4 cups a day
  • 8. Pregnant women, women who are breastfeeding, or women who intended to fall pregnant.
  • 9. Currently taking supplements that may impact on treatment outcome

研究者

发起方
Clinical Research Australia

相似试验